Speed 2023
Submission to first editorial decision (median days): 13
Submission to acceptance (median days): 96
Usage 2023
Downloads: 167,495
Altmetric mentions: 29
Editor-in-Chief
Yongchao Su, PhD, Merck, West Point, PA, USA
yongchao.su@merck.com
Editors
Xiuling Lu, PhD, FAAPS, University of Connecticut, Storrs, CT, USA
Mohammed Maniruzzaman, PhD, University of Mississippi, Oxford, MS, USA
Dana Moseson, PhD, Pfizer, Groton, Connecticut, USA
Yihong Qiu, PhD, AbbVie, Vernon Hills, IL, USA
Chun-Wan Yen, PhD, Genentech, San Francisco, CA, USA
Editorial Advisory Board
Ian Blagbrough, PhD, University of Bath, Bath, UK
Ahmed Besheer, PhD, Lonza, Basel, Switzerland
Kaushalendra Chaturvedi, PhD, J-STAR Research Inc., Cranbury, NJ, USA
Kang Chen*, PhD, Food and Drug Administration, Silver Springer, MD, USA
*Serving in their personal capacity
David Cipolla, MD, Insmed Incorporated, New York City, NY, USA
Ana Sara Cordeiro, PhD, De Montfort University, Leicester, UK
Tapan Das, PhD, Spyre Therapeutics, Princeton, NJ, USA
Binodh DeSilva, PhD, Ultragenyx, Princeton, NJ, USA
Vivian Gray, BSc, VA Gray Consulting, Hockessin, DE, USA
Timothy Hickling, PhD, Roche/Genentech, Basel, Switzerland
Kim Huynh-Ba, PhD, Pharmalytik, Newark, DE USA
Hyunyoung Jeong, PharmD, PhD, Purdue University, West Lafayette, IN, USA
Tarik Khan, PhD, Roche / Genentech, Basel, Switzerland
Lakshmi Prasanna, PhD, Astra Zeneca, UK
John Lough, BSc, PhD, CChem, FRSC, FChromSoc, School of Pharmacy and Pharmaceutical Sciences, University of Sunderland, UK
Christopher McCurdy, PhD, BSPh, FAAPS, University of Florida, , USA
Ehab Moussa, PhD, Abbvie, North Chicago, IL, USA
Sakya Mohapatra, ReCode Therapeutics, San Francisco, CA, USA
Arnab Mukherjee, PhD, Pfizer, New London, CT USA
Anette Müllertz, PhD, University of Copenhagen, Copenhagen, Denmark
Douhai Pan, Bristol Myers Squibb, New Brunswick, NJ USA
Komal Patel, MS, Kenox Pharmaceuticals
Changquan Calvin Sun, PhD, University of Minnesota, Minnesota, MN, USA
Harsh Shah, PhD, J-STAR Research Inc., New Jersey, US
Mehran Yazdanian, BSc, Teva Branded Pharmaceutical Products R&D Inc., USA
Qi (Tony) Zhou, PhD, Purdue University, USA
AAPS
Matthew Baughman, AAPS, United States of America
Speed 2023
Submission to first editorial decision (median days): 13
Submission to acceptance (median days): 96
Usage 2023
Downloads: 167,495
Altmetric mentions: 29